These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36291020)

  • 21. Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer's disease brains: Implications for in-vivo diagnostics.
    den Haan J; Morrema THJ; Rozemuller AJ; Bouwman FH; Hoozemans JJM
    Acta Neuropathol Commun; 2018 Aug; 6(1):75. PubMed ID: 30092839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: implications for Alzheimer disease pathogenesis.
    Terron HM; Parikh SJ; Abdul-Hay SO; Sahara T; Kang D; Dickson DW; Saftig P; LaFerla FM; Lane S; Leissring MA
    Alzheimers Res Ther; 2024 Apr; 16(1):70. PubMed ID: 38575959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interplay between tauopathy and aging through interruption of UPR/Nrf2/autophagy crosstalk in the Alzheimer's disease transgenic experimental models.
    Amini J; Sanchooli N; Milajerdi MH; Baeeri M; Haddadi M; Sanadgol N
    Int J Neurosci; 2024 Oct; 134(10):1049-1067. PubMed ID: 37132251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanomaterial-based Optical and Electrochemical Biosensors for Amyloid beta and Tau: Potential for early diagnosis of Alzheimer's Disease.
    Phan LMT; Hoang TX; Vo TAT; Pham HL; Le HTN; Chinnadayyala SR; Kim JY; Lee SM; Cho WW; Kim YH; Choi SH; Cho S
    Expert Rev Mol Diagn; 2021 Feb; 21(2):175-193. PubMed ID: 33560154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease.
    Folwell J; Cowan CM; Ubhi KK; Shiabh H; Newman TA; Shepherd D; Mudher A
    Exp Neurol; 2010 Jun; 223(2):401-9. PubMed ID: 19782075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cl-NQTrp Alleviates Tauopathy Symptoms in a Model Organism through the Inhibition of Tau Aggregation-Engendered Toxicity.
    Frenkel-Pinter M; Tal S; Scherzer-Attali R; Abu-Hussien M; Alyagor I; Eisenbaum T; Gazit E; Segal D
    Neurodegener Dis; 2017; 17(2-3):73-82. PubMed ID: 27760426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of Dual Aβ/Tau Inhibitors and Evaluation of Their Therapeutic Effect on a
    Gandini A; Gonçalves AE; Strocchi S; Albertini C; Janočková J; Tramarin A; Grifoni D; Poeta E; Soukup O; Muñoz-Torrero D; Monti B; Sabaté R; Bartolini M; Legname G; Bolognesi ML
    ACS Chem Neurosci; 2022 Dec; 13(23):3314-3329. PubMed ID: 36445009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus.
    Zhang ZX; Zhao RP; Wang DS; Li YB
    Neurochem Res; 2016 Nov; 41(11):3074-3082. PubMed ID: 27518086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of high-fat diet-induced miRNA ameliorates tau toxicity in Drosophila.
    Singh MK; Ryu TH; Nguyen MN; Yu K
    Biochem Biophys Res Commun; 2024 Nov; 733():150446. PubMed ID: 39067249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated biology approach reveals molecular and pathological interactions among Alzheimer's Aβ42, Tau, TREM2, and TYROBP in Drosophila models.
    Sekiya M; Wang M; Fujisaki N; Sakakibara Y; Quan X; Ehrlich ME; De Jager PL; Bennett DA; Schadt EE; Gandy S; Ando K; Zhang B; Iijima KM
    Genome Med; 2018 Mar; 10(1):26. PubMed ID: 29598827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Qingyangshen mitigates amyloid-β and Tau aggregate defects involving PPARα-TFEB activation in transgenic mice of Alzheimer's disease.
    Iyaswamy A; Krishnamoorthi SK; Zhang H; Sreenivasmurthy SG; Zhu Z; Liu J; Su CF; Guan XJ; Wang ZY; Cheung KH; Song JX; Durairajan SSK; Li M
    Phytomedicine; 2021 Oct; 91():153648. PubMed ID: 34332287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurotherapy of Yi-Gan-San, a Traditional Herbal Medicine, in an Alzheimer's Disease Model of
    Su MT; Jheng YS; Lu CW; Wu WJ; Yang SY; Chuang WC; Lee MC; Wu CH
    Plants (Basel); 2022 Feb; 11(4):. PubMed ID: 35214904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired retrograde transport by the Dynein/Dynactin complex contributes to Tau-induced toxicity.
    Butzlaff M; Hannan SB; Karsten P; Lenz S; Ng J; Voßfeldt H; Prüßing K; Pflanz R; Schulz JB; Rasse T; Voigt A
    Hum Mol Genet; 2015 Jul; 24(13):3623-37. PubMed ID: 25794683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The central role of tau in Alzheimer's disease: From neurofibrillary tangle maturation to the induction of cell death.
    Thal DR; Tomé SO
    Brain Res Bull; 2022 Nov; 190():204-217. PubMed ID: 36244581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term exposure to dim light at night disrupts rhythmic behaviors and causes neurodegeneration in fly models of tauopathy and Alzheimer's disease.
    Kim M; Subramanian M; Cho YH; Kim GH; Lee E; Park JJ
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1722-1729. PubMed ID: 29217196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant Neuronal Tau Deposition and FKBP52 Decrease Is an Early Feature of Different Human and Experimental Tauopathies.
    Meduri G; Guillemeau K; Daguinot C; Dounane O; Genet M; Ferrara L; Chambraud B; Baulieu EE; Giustiniani J
    J Alzheimers Dis; 2023; 94(1):313-331. PubMed ID: 37248902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenic Drosophila models of Alzheimer's disease and tauopathies.
    Iijima-Ando K; Iijima K
    Brain Struct Funct; 2010 Mar; 214(2-3):245-62. PubMed ID: 19967412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood-based Aβ42 increases in the earliest pre-pathological stage before decreasing with progressive amyloid pathology in preclinical models and human subjects: opening new avenues for prevention.
    Botella Lucena P; Vanherle S; Lodder C; Gutiérrez de Ravé M; Stancu IC; Lambrichts I; Vangheluwe R; Bruffaerts R; Dewachter I
    Acta Neuropathol; 2022 Sep; 144(3):489-508. PubMed ID: 35796870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active full-length DNA Aβ
    Rosenberg RN; Fu M; Lambracht-Washington D
    Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of tau protein in Alzheimer's disease: The prime pathological player.
    Muralidar S; Ambi SV; Sekaran S; Thirumalai D; Palaniappan B
    Int J Biol Macromol; 2020 Nov; 163():1599-1617. PubMed ID: 32784025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.